Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
WHO Drug Information Vol. 13, No. 4, 1999
(1999; 83 pages) View the PDF document
Table of Contents
Open this folder and view contentsGeneral Policy Issues
Open this folder and view contentsReports on Individual Drugs
Open this folder and view contentsCurrent Topics
Open this folder and view contentsVaccines and Biomedicines
Open this folder and view contentsRegulatory and Safety Matters
Open this folder and view contentsATC/DDD Classification
Open this folder and view contentsEssential Drugs
View the documentInternational Nonproprietary Names for Pharmaceutical Substances (INN)
View the documentSelected WHO Publications of Related Interest
 

WHO Drug Information Vol. 13, No. 4, 1999

RECOMMENDED INN LIST 82

INTERNATIONAL NONPROPRIETARY NAMES FOR PHARMACEUTICAL SUBSTANCES

WORLD HEALTH ORGANIZATION • GENEVA

WHO DRUG INFORMATION

WHO Drug Information provides an overview of topics relating to drug development and regulation that are of current relevance and importance, and includes the lists of proposed and recommended International Nonproprietary Names for Pharmaceutical Substances (INN). Its contents reflect, but do not present, WHO policies and activities and they embrace socioeconomic as well as technical matters.

The objective is to bring issues that are of primary concern to drug regulators and pharmaceutical manufacturers to the attention of a wide audience of health professionals and policy-makers concerned with the rational use of drugs. In effect, the journal seeks to relate regulatory activity to therapeutic practice. It also aims to provide an open forum for debate. Invited contributions will portray a variety of viewpoints on matters of general policy with the aim of stimulating discussion not only in these columns but wherever relevant decisions on this subject have to be taken.

WHO Drug Information is published 4 times a year and can be ordered from: Marketing and Dissemination, World Health Organization, 1211 Geneva 27, Switzerland.

Annual subscription rate: Sw.fr. 75.—
Price per copy: Sw.fr. 25.—
(30% reduction in price for developing countries.)

Information concerning WHO Drug Information can be viewed at:
http://www.who.int/dsa

©World Health Organization 1999

Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. All rights reserved. For rights of reproduction or translation, in part or in toto, application should be made to: Coordinator, Publications, World Health Organization, 1211 Geneva 27, Switzerland. The World Health Organization welcomes such applications.

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city, or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

Authors alone are responsible for views expressed in signed contributions.

The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature which are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

ISSN 1010-9609

Printed in Malta
99/12438 - Interprint - 5300

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014